301206 三元生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)1.5312.3251.2235.77868.853
总资产报酬率 ROA (%)1.4512.1841.1575.03344.331
投入资产回报率 ROIC (%)1.4882.2331.1775.20947.606

边际利润分析
销售毛利率 (%)16.15311.1063.05014.05541.991
营业利润率 (%)16.33817.94711.70927.56736.994
息税前利润/营业总收入 (%)15.21716.57710.20518.89637.282
净利润/营业总收入 (%)14.13314.72211.20824.25331.959

收益指标分析
经营活动净收益/利润总额(%)32.54814.140-87.35749.97898.712
价值变动净收益/利润总额(%)66.00284.692189.98946.8290.041
营业外收支净额/利润总额(%)-0.0170.2030.566-1.1400.020

偿债能力分析
流动比率 (X)21.08413.9041.4353.2261.426
速动比率 (X)19.75913.3190.9702.7591.228
资产负债率 (%)3.7256.5355.6665.11636.033
带息债务/全部投入资本 (%)0.7101.9903.4332.21229.487
股东权益/带息债务 (%)13,800.0274,850.0412,783.6894,380.713233.765
股东权益/负债合计 (%)2,584.2361,430.1231,664.8551,854.666177.527
利息保障倍数 (X)-13.610-11.787-6.498-2.260132.862

营运能力分析
应收账款周转天数 (天)52.94949.88646.74651.30522.808
存货周转天数 (天)96.54070.16774.75064.83633.406